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Research Institute, Watertown, MassachusettsABSTRACT In skeletal muscle, excitation-contraction coupling involves the activation of dihydropyridine receptors (DHPR)
and type-1 ryanodine receptors (RyR1) to produce depolarization-dependent sarcoplasmic reticulum Ca2þ release via ortho-
grade signaling. Another form of DHPR-RyR1 communication is retrograde signaling, in which RyRs modulate the gating of
DHPR. DP4 (domain peptide 4), is a peptide corresponding to residues Leu2442-Pro2477 of the central domain of the RyR1
that produces RyR1 channel destabilization. Here we explore the effects of DP4 on orthograde excitation-contraction coupling
and retrograde RyR1-DHPR signaling in isolated murine muscle fibers. Intracellular dialysis of DP4 increased the peak ampli-
tude of Ca2þ release during step depolarizations by 64% without affecting its voltage-dependence or kinetics, and also caused
a similar increase in Ca2þ release during an action potential waveform. DP4 did not modify either the amplitude or the voltage-
dependence of the intramembrane charge movement. However, DP4 augmented DHPR Ca2þ current density without affecting
its voltage-dependence. Our results demonstrate that the conformational changes induced by DP4 regulate both orthograde E-C
coupling and retrograde RyR1-DHPR signaling.INTRODUCTIONIn skeletal muscle, depolarization of the transverse tubule
system is detected by the dihydropyridine receptor (DHPR),
a Cav1 Ca2þ channel. Upon depolarization there is a reorien-
tation of charged residues in transmembrane domains of
DHPR that results in the activation of sarcoplasmic reticulum
(SR) Ca2þ release from the ryanodine receptor (RyR1) (1–4).
The signal received by the RyR is recognized by a Ca2þ
conduction pathway located at the opposite side of the
RyR. This sequential activation of DHPR and RyR1 to
produce depolarization-dependent Ca2þ release is known as
orthograde signaling (5–7). Another form of DHPR-RyR1
communication is the retrograde signaling, in which RyRs
modulate the gating of DHPR (8–11). In addition to this
DHPR-RyR1 signaling, the RyR1 Ca2þ release channel is
subject to different forms of both extrinsic and intrinsic
modulation. For instance, a variety of intracellular factors
(such as Ca2þ, Mg2þ, calmodulin, and S100A1) extrinsically
modulates the RyR1 activity (12–16).
The intrinsicmodulation of opening/closing of the SRCa2þ
release channels seems to be performed by global conforma-
tional changes of the RyR1 molecule, as indicated by high-
resolution single particle analysis of cryo-electronmicroscopy
images of RyR1 in its resting and activated states (17). Recent
peptide probe studies of local conformational changes within
the RyR1 have led to the hypothesis that the extent of interdo-Submitted August 7, 2010, and accepted for publication April 4, 2011.
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0006-3495/11/05/2367/11 $2.00main interaction between an N-terminal domain and a central
domain of RyR1 (designated as a domain switch) is involved
in the channel regulation, thus playing an important role in the
conformational regulation of RyR1 functions (18).
This hypothesis is consistent with the observations that
domain peptide 4 (DP4), a decoy peptide corresponding to
the Leu2442-Pro2477 region of the central domain, binds
to the 51-kDa region including the N-terminus and activates
the RyR1 channel (19). This suggests that there is an interdo-
main interaction between N-terminal domain and central
domain, and that this interaction stabilizes the closed state
of the channel. A variety of other observations is also consis-
tent with this hypothesis (20–25). As is the case of increased
sensitivity to caffeine or other agonists in malignant hyper-
thermia (MH) (26–30), DP4 (30–100 mM) was also found to
increase the sensitivity to caffeine for channel activation (22).
Previous work in skeletal muscle has also shown that DP4
enhanced force response to submaximal depolarization by
ionic substitution in mechanically skinned fibers (31) and
increased the frequency of Ca2þ sparks in permeabilized
amphibian fibers (23). However, the influence of DP4 on
voltage-clamp depolarization-evoked Ca2þ release has not
been evaluated. In this work, we sought to explore effects
of DP4 on orthograde excitation-contraction (E-C) coupling
and retrograde RyR1-DHPR signaling in whole-cell,
voltage-clamped adult murine skeletal muscle fibers.MATERIALS AND METHODS
Ethical approval
All animals were housed in a pathogen-free area at the University of
Maryland, Baltimore. The animals were euthanized according to authorizeddoi: 10.1016/j.bpj.2011.04.012
2368 Olojo et al.procedures of the Institutional Animal Care and Use Committee, University
of Maryland, Baltimore.FDB fiber preparation
Fibers were prepared using enzymatic dissociation of FDB muscles of 6–7-
week-old C57BL mice, and were cultured as previously described (32).Peptide synthesis
The amino-acid sequence of the synthetic peptides corresponding to the
selected subdomains of RyR1 DP4 is
2442LIQAGKGEALRIRAILR
SLVPLDDLVGIISLPLQIP2477
and Mutant DP4 is
2442LIQAGKGEALRIRAILC
SLVPLDDLVGIISLPLQIP2477
with R2458C substitution were synthesized as previously described
(22–24).Solutions
Whole-cell Ca2þ current and charge movement measurements were carried
out as previously described (33). The standard pipette solution (internal)
contained: 140 mM Cs-CH3SO3, 10 mM HEPES, 20 mM EGTA, 6 mM
MgCl2, 11.5 mM CaCl2, 4 mM Na2ATP, 14 mM creatine phosphate,
0.3 mM Na2GTP, and 0.1 mM leupeptin and solution pH adjusted to
7.4 with CsOH to obtain a buffered solution. Fibers were dialyzed via the
patch pipette with 50–75 mM fluo-4 5 Kþ. Where noted, 50–100 mM DP4
or mutant DP4 was also included in the internal solution. Fibers were dia-
lyzed for exactly 20 min before the start of data acquisition.Electrophysiology and data analysis
Membrane current measurements were performed using the whole-cell
configuration of the patch-clamp technique (34) with modifications for
mammalian FDB fibers detailed elsewhere (33,35). For results shown later
in Fig. 6, A–D, a muscle action potential was recorded in current clamp
mode and then used as the command voltage (36).Fluo-4 high-speed line-scan (x-t) confocal
microscopy
Fluo-4 fluorescence measurements were carried out on an LSM 5 Live
system (Carl Zeiss, Jena, Germany) as previously described (37). Average
intensity of fluorescence as a function of time (F(x,t)) within a selected
segment of the scan line within a fiber was measured using Image Examiner
(Carl Zeiss). The average F0 value in each line segment before test pulse is
used to scale fluo4 fluorescence in the same region as F/F0.Time course of free Ca2D concentration
Free Ca2þ was calculated from the F/F0 record by correcting for kinetic lag
and dye saturation using an approach previously described (38) but adapted
here for F/F0 records (see (39)). Under conditions when the dye is not at
equilibrium with the cytosolic free Ca2þ, the time course of cytosolic
free Ca2þconcentration ([Ca]cyto(t)), is given byBiophysical Journal 100(10) 2367–2377½CacytoðtÞ ¼ KDdfð1=koffdÞ dFðtÞ=dt
(1)þ FðtÞ  Fming=fFmax  FðtÞg
(see (38), Eq. 5, with rearrangements), whereKDd is the dissociation constant
for Ca2þ from the indicator dye, koffd is the off rate constant for Ca
2þ disso-
ciation from the dye, F is the fiber fluo-4 fluorescence signal and Fmax and
Fmin are the fluorescence at saturating and zero free Ca
2þ, respectively.
When the concentration is changing slowly, the followingcondition applies:
½CazKDdfðF FminÞ=ðFmax  FÞg: (2)
Then, average [Ca2þ]cyt (t) is derived from F(t)/F0 (39) as
½Ca2þcytoðtÞ ¼ ½Ca2þcytoð0ÞfðFðtÞ=F0Þ
þ ð1=koffdÞ dðFðtÞ=F0Þ=dtg; (3)
where [Ca2þ]cyto(0) is free cytosolic [Ca2þ] at resting levels. This equation
assumes that the dye is far from saturation by Ca2þ, which appears justified
for fluo-4 considering that [Ca2þ]cyto was always much lower than the
value of fluo-4’s KD previously determined using in situ calibrations
(37). [Ca2þ]cyto(0) was set equal to 0.081 mM, the average value measured
in parallel studies using indo-1 in voltage-clamped FDB fibers with and
without 50 mM DP4. If we use the nonsignificantly different mean resting
[Ca2þ] of 75 and 86 nM for control and DP4-dialyzed fibers, respectively,
the calculated percent increase in peak Ca2þ release flux induced by DP4
for pulses to þ20 mV would be 6% larger than presented here.Calculation of Ca2D release flux
Time course of the rate of change of [Ca-EGTA]
Under the conditions of 20 mM EGTA with added Ca2þ in the pipette,
EGTA is still the major binding site for released Ca2þ. In that case
d [Ca-EGTA](t)/dt provides a good approximation to the rate of SR Ca
release in the fiber, and will be used in the Ca2þ release calculations pre-
sented here. For Ca2þ binding to EGTA,
d½Ca - EGTAðtÞ=dt ¼ kone½CaðtÞ½EGTAðtÞ
 koffe½Ca - EGTAðtÞ; (4)
where kone and koffe are on- and off-rate constants for Ca
2þ binding to
EGTA. Because
½EGTAðtÞ ¼ ½EGTAtot½Ca - EGTAðtÞ;
d½Ca - EGTAðtÞ=dt ¼ kone½CaðtÞ
½EGTAtot
 ½Ca - EGTAðtÞ
 koffe½Ca - EGTAðtÞ:
(5)
Equation 5 was solved numerically using [Ca2þ]cyto(t) from Eq. 3, and
using the Euler method to calculate the time course of d[Ca-EGTA](t)/dt,
which was used as the time course of the rate of Ca2þ release from the
SR during the voltage-clamp pulses. [EGTA]tot in the fiber was assumed
to be 70% of that in the pipette solution. [EGTA] and [Ca-EGTA] inside
the fiber at the start of each pulse were calculated from [EGTA]/
[Ca-EGTA] ¼ KDe/[Ca2þ] and from the conservation of total EGTA. The
parameter values used in our calculations were koffd ¼ 90 s1 (40),
kone ¼ 15 (mM s)1 (39) and koffe ¼ 1.2 s1 (EGTA KD ¼ 0.08 mM).Statistical analysis
All statistical analysis was performed using ORIGINPro 8.0 (http://www.
originlab.com/). All data are presented as mean 5 SE unless otherwise
DP4 Regulates E-C Coupling 2369noted. Statistical significance was assessed using either parametric two
sample t-test or with the nonparametric Mann-Whitney rank-sum test.
Significance was set at P < 0.05.RESULTS
Depolarization-evoked fluo-4 fluorescence
signals in a control and in a DP4-dialyzed fiber
The first series of experiments aimed to evaluate the effects
of DP4 on DHPR to RYR communication (i.e., orthograde
signaling). Fig. 1 illustrates the protocol used for monitoring
Ca2þ transients in these studies. FDB muscle fibers isolated
from C57BL mice were voltage-clamped at a holding poten-
tial of 80 mV. In these experiments, 50 mM fluo-4 was
included in the patch pipette solution, and was allowed to
diffuse into the fiber for exactly 20 min after seal formation
and before starting data acquisition. A bracketing set of
pulses to 20 mV was applied before and after each pair
of pulses to another voltage to monitor stability of the fiber.
Fig. 1 shows raw fluo-4 fluorescence Ca2þ transients
obtained from a control fiber (Fig. 1 A) and from a DP4-dia-
lyzed fiber (Fig. 1 B) using series of 80-ms voltage-clamp
step depolarizations increasing in amplitude by 20 mV,
with a 30-s interval between pulse applications. The
20-min time interval for diffusion of pipette solution into
the fiber before starting data acquisition and the 30-s
interval between applications of successive pulses were
strictly adhered to in all experiments. Confocal line-scan
images were acquired at 50 or 100 ms/line synchronized to
start 300 ms before each of the pulses during step
depolarizations.
Using the voltage protocol illustrated in Fig. 1 C, a detect-
able fluo-4 fluorescence change was typically first detected
in most fibers with pulses to above 40 mV, and saturatedwith pulses to ~þ20 mV. It was observed that the resting
fluorescence (F0) increased during the course of the succes-
sive pulse applications, leading to increased baseline F0
values as shown in Fig. 1, D and E. The resting fluorescence
before starting the application of successive depolarizing
pulses is marked as F0(20,start) and the background fluo-
rescence Fb (set to zero by background subtraction) are as
illustrated in Fig. 1,D and E. The amplitude of theDF signal
for the repeated pulses to 20 mV appears to be changing
with time and/or with the intervening pulses and the accom-
panying successive Ca2þ release and uptake. The value of
F0 was continuously increasing with time over the course
of each experiment. In view of the strong Ca2þ buffering
by EGTA in these experiments, we believe that the
increasing F0 was due to increasing entry of fluo-4/EGTA
during the course of the experiment rather than to an
increase in resting [Ca2þ] (see below). In any case, careful
examination of the changes in both F0 and DF indicated
that both were changing over the course of the experiment
(see Fig. S1 in the Supporting Material).Resting [Ca2D] in control and DP4 dialyzed fibers
To experimentally determine the resting [Ca2þ] under the
conditions of our experiments, we carried out a parallel
set of experiments using indo-1 in the pipette instead of
fluo-4, with all other constituents being the same (see
additional Materials and Methods in the Supporting Mate-
rial). The indo-1 fluorescence emission ratio did not change
significantly with time starting 20 min after whole-cell
configuration establishment (Fig. S2 C), although the ab-
solute fluorescence did (Fig. S2 D), indicating continued
indo-1 entry. Furthermore, the indo-1 fluorescence ratio,
and the free [Ca2þ] calculated from it were not significantlyFIGURE 1 Depolarization-evoked fluo-4 Ca2þ
transients in a control fiber and in another fiber
studied with 50 mM DP4 in the internal solution.
(A, open box) Region of interest drawn in the
center of the fiber that was used to measure fluores-
cence intensity. (B) Representative confocal line
scan (x-t) fluo4 images synchronized with the
voltage-clamp protocol, consisting of 80-ms depo-
larizing steps from a holding potential of 80 mV
to the voltages indicated next to the images, from
a fiber dialyzed with the standard control internal
solution (A) or from a different fiber dialyzed
with a DP4-containing internal solution. (C)
Voltage protocol. (D and E) Time course of
fluo-4 fluorescence obtained from panels A and
B. (F andG) Superimposed F/F0 traces empirically
corrected (see Results), relative to 20 mV depo-
larization in the middle of the protocol for a control
and a DP4-dialyzed fiber, respectively. (Arrows)
Superimposed traces obtained with the pulses at
20 mV.
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solution (Fig. S2, A and B). These results provide strong
support for the interpretation that the resting free [Ca2þ] is
fully controlled by the EGTA buffer at a constant level
throughout each of our experiments, which began at
20 min after seal formation. It then continued for, at most,
another 7 or 8 min, and the resting free [Ca2þ] level was
not significantly different with or without DP4 (86 nM vs.
75 nM, respectively; P> 0.05). Thus, the increase in resting
fluorescence with time in the experiments using fluo-4
appears to be the result of increasing concentration of the
fluo4 rather than a change in free [Ca2þ].Empirical correction for changes during dye entry
To compensate for possible changes in the fiber with time
during application of the pulse sequence in Fig. 1, regardless
of the mechanism involved, we used the records for the
repeated pulses to 20 mV in each fiber to calculate
model-independent empirical compensation factors. DF/F0
was calculated for each pulse in the sequence in each fiber.
The DF/F0 records for the pulses to 20 mVat the start and
end of the sequence were scaled to the DF/F0 record for theBiophysical Journal 100(10) 2367–2377pulse to 20 mV in the middle of the sequence. The scaled
records showed excellent agreement (records marked by
arrows in Fig. 1, F and G; three records superimposed).
The intervening pulses (to 60 and 40 mV between the
start- and mid-pulse to 20 mV, and the pulses to
0 and þ20 mV between the mid- and end-pulse to
20 mV) were scaled by one- or two-thirds of the scale
factor for the bracketing pulses to 20 mV in each fiber,
giving the other records in Fig. 1, F and G. Such scaled
records were then represented as F/F0 relative to the middle
20 mV pulses and used for all further calculations for
each fiber.DP4 potentiates fluorescence signals, free Ca2D,
and Ca2D release flux in DP4-dialyzed FDB fibers
Fig. 2 shows an averaged time course of fluo-4 Ca2þ tran-
sients elicited by 80-ms step depolarization and expressed
as F/F0 obtained from control (Fig. 2 A, N ¼ 5) and
50 mM DP4-dilayzed fibers (Fig. 2 D, N ¼ 5) both with
application of an initial and final voltage pulse to 20 mV
and a series of pulse voltages in between from 60 mV
to þ20 mV at 20 mV step increments, as shown in Fig. 1.FIGURE 2 Fluo-4 fluorescence transients, free
[Ca2þ] and Ca2þ release flux from control and
DP4-dialyzed fibers. Average (N ¼ 5) fluo-4 DF/
F0 records expanded in time using pulse protocol
shown in Fig. 1 from control (A) and from 50
mM DP4 dialyzed fibers (D). (B and E) Free
[Ca2þ] waveforms derived from panels A and D
calculated using Eq. 3 (see Materials and
Methods). (C and F) Ca2þ release flux, calculated
from Eq. 5. Comparison of the two sets of data
show potentiation of Ca2þ signals by addition of
DP4.
FIGURE 3 DP4 at 100 mM potentiates voltage-dependent Ca2þ release
flux. Time course of the averaged Ca2þ release flux for control (A),
100 mM DP4-dialyzed fibers (B), and 100 mM Mut-DP4-dialyzed fibers
(C) in response to test depolarizations indicated (top of figure). (Green)
Ca2þ release records for the repeated pulses to 20 mV. Addition of
100 mM DP4 potentiates the amplitude of Ca2þ release flux. Ca2þ release
flux was calculated from Eq. 5. (D) Average peak release records plotted
versus voltage (R-V) relationships for Mut-DP4 (blue symbols), control
(black symbols), and 100 mM DP4-dialyzed fibers (red symbols). Contin-
uous lines through the symbols are best fits to a single Boltzmann function
from Eq. 6 (see Results). (E) Normalized peak Ca2þ release versus voltage,
showing that DP4 dialysis does not change the Vhalf of the R-V relationship
when compared to the control counterpart. These results reveal a significant
64% enhancement (N ¼ 4; * P < 0.05) in Rmax induced by 100 mM DP4.
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course of each experiment described above was applied to
give the presented F/F0 records (Fig. 2, A and D), and
such records were used to calculate the free cytosolic
Ca2þ concentration (free [Ca2þ]). The estimation of the
Ca2þ release flux in each fiber was then calculated from
its free Ca2þ waveform.
For each fiber, Eq. 3 was used to calculate average cyto-
solic free [Ca2þ], whereas the rate of Ca2þ release from the
inside of the SR into the cytosol was calculated using Eq. 5
(see additional Materials and Methods in the Supporting
Material). Fig. 2, B and C, on the left presents the average
of the records of free [Ca2þ] and Ca2þ release flux from
five fibers for the control measurements, whereas corre-
sponding data on the right (Fig. 2, E and F) are the averages
from five fibers dialyzed with 50 mM DP4. DP4 increased
the average fluo-4 signal at each voltage, and increased
the calculated free Ca2þ as well as the magnitude of the
peak Ca2þ release (peak Ca2þ release atþ20 mV for control
fibers ¼ 38.45 7.7 mMms1 vs. 56.95 10.2 mMms1 for
DP4-dialyzed fibers; n ¼ 5, P < 0.05).
In another series of experiments (Fig. 3), fibers were dia-
lyzed with 100 mMDP4, or with 100 mM of DP4 mutated at
residue 2458 (R2458C substitution; hereafter referred to as
Mut-DP4), or with control internal solution without any
DP4 or Mut-DP4. Here the pulse sequence for the first
half of the experiment was identical to that in Figs. 1 and
2, but was followed by another sequence of pulses ranging
from þ10 to 50 mV of decreasing amplitude in 20 mV
increments, with a reference pulse to 20 mV at the start,
middle, and end of the sequence. Correction for changes
with time was identical to that used for the first sequence.
The second sequence was then normalized to the first by
scaling all records in the second sequence by the ratio of
the DF/F0 values for the middle pulse, to 20 in the first
sequence, to that in the second sequence.
Fig. 3 presents averages of Ca2þ release flux profiles
obtained from four control fibers (Fig. 3 A), four fibers dia-
lyzed with 100 mM DP4 (Fig. 3 B), or four fibers dialyzed
with 100 mM Mut-DP4 (Fig. 3 C). The dialysis of 100 mM
DP4 further enhanced the peak Ca2þ release rates when
compared to 50 mM DP4 described in earlier experiments
(Fig. 2), whereas the 100mMMut-DP4 produced peak values
similar to the control. The records for the repeated pulses to
20 mVare shown in green. Comparison of the three panels
shows elevation of Ca2þ release flux at intermediate and
extreme positive voltages in the presence of 100 mM DP4.
Using data obtained from each of the fibers used in Fig. 3,
A–C, average values of the peak release rate were calculated
and plotted as a function of voltage (R-V profiles in
Fig. 3 D). The data were fitted to a single Boltzmann func-
tion described by the equation (37)
RðVÞ ¼ Rmax=

1þ expVhalf  V

k

; (6)where Rmax is the maximum release rate, Vhalf defines the
potential when R ¼ 0.5 Rmax, and 1/k is a measure of the
steepness of the R-V relationship. Average 5 SE for Rmax,
Vhalf, and k parameters were: 32.1 5 2.2 mM ms
1,
18 5 2.8 mV, and 12.1 5 2 mV; 40.3 5 1.2 mM ms1,
24 5 1.2 mV, and 10.3 5 1 mV; and 66.1 5 1.2 mM
ms1, 26 5 0.7 mV, and 8.2 5 0.6 mV for Mut-DP4,
control, and DP4-dialyzed fibers, respectively. This analysis
reveals a significant 64% enhancement (N ¼ 4; P < 0.05) in
the maximum peak Ca2þ release with the addition of
100 mM DP4 when compared to the control fibers.
Fig. 3 E plots the R-V curves normalized to Rmax, allowing
a better visualization of the effects of DP4 on the voltage
dependence and steepness of the Ca2þ release. The Vhalf
values shown here indicate a nonsignificant change in the
voltage-dependence of Ca2þ release arising from addition
of DP4 (Fig. 3, D and E). The mutant-DP4 did not produce
a significant change in the amplitude of the Ca2þ release
(P > 0.05).
To evaluate the kinetic effect of the addition of 100 mM
DP4, Ca2þ release flux profiles for control and 100 mM
DP4-dialyzed fibers were plotted together and normalizedBiophysical Journal 100(10) 2367–2377
2372 Olojo et al.to the peak values for selected voltages that elicited Ca2þ
release, i.e., 20 mV, 10 mV, 0 mV, and þ20 mV
(Fig. 4, A–D). The insets show expanded timescale plots
of the same records. Each of the Ca2þ release waveforms
is characterized by a pronounced early peak that occurs
within 10 ms of the application of these larger pulse depo-
larizations. This is then followed by an initial rapid decline
and a much slower decline with time in a profile that is
believed to reflect an early partial inactivation of the
RyR1 and the later effect of a time-dependent decline of
the SR Ca2þ content, respectively (41,42). The kinetics of
the peak formation and the initial decline appear unchanged
by DP4 from the overlay of the normalized Ca2þ release
peak (Fig. 4, A–D). Intermediate and large depolarizations
produced a relatively faster decline of the slower component
of the Ca2þ release, which may be attributed to enhanced
decline of the SR Ca2þ content.
It has been suggested that the affinity of EGTA may be
lower in the fiber interior than in free solution (39). A reduc-
tion in effective value of KD has been demonstrated directly
for the EGTA-based fluo-3 and is attributed to its binding to
intracellular proteins and its engaging in multimolecularFIGURE 4 Control and DP4-dialyzed fibers demonstrate almost identical rela
analyzed at 20 (A), 10 (B), 0 (C), and þ20 mV (D), in both the control and
Zoom-in versions of the rising phase of Ca2þ release and the comparison of p
decline of Ca2þ release appear to be minimally affected in DP4-dialyzed fibers
Biophysical Journal 100(10) 2367–2377reactions (43), a complication due to the intracellular envi-
ronment (44). We therefore examined the effect on our anal-
ysis of assuming a lower EGTA affinity in the fiber by
changing koffe from 1.2 to 7.5, corresponding to an increase
in EGTA KD from 0.08 to 0.5 mM. When we made this
change in parameter values, the absolute amplitude of the
peak release was increased by 74% with DP4 and by 72%
without DP4 (see Fig. S3, A and B), giving essentially the
same relative effect of DP4 (46% enhancement) for either
calculation of peak release (see insets in Fig. S3, A and B).
Furthermore, the early time courses of normalized release
flux for the calculations with the two values of koffe were
entirely unaffected, and only a very minor change in time
course was produced in the late phase of release by changing
koffe (see Fig. S3, C and D). Thus, our calculations are very
insensitive to the Ca2þ affinity used for EGTA in the fiber.Nonlinear charge movement currents
are unchanged with addition of DP4
We also evaluated charge movement parameters in fibers
dialyzed with 75 mM DP4 (see Fig. S4), and found notive time courses of Ca2þ release. Normalized Ca2þ release versus time was
DP4-dialyzed fibers to evaluate the kinetic effect of 100 mM DP4. (Insets)
lots from control and DP4-dialyzed fibers. The rising phase and the initial
.
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steepness of voltage dependence of charge movement in
DP4-dilayzed fibers when compared to control counterparts
(P > 0.05, N ¼ 5).Whole cell Ca2D channel current is enhanced
with dialysis of DP4
We next examined whether DP4 also caused changes in
RyR1 to DHPR communication (i.e., retrograde signaling).
To this end, we measured whole-cell Ca2þ currents gener-
ated by the DHPR in control and in DP4-dialyzed fibers.
Fig. 5 A shows representative macroscopic Ca2þ current
traces from a control (black trace), Mut-DP4-dialyzed
(blue trace, 100 mM), and DP4-dialyzed fibers (red trace,
100 mM) using step depolarizations lasting 80 ms applied
from a holding potential of 80 mV. Traces shown were
obtained at 0 mV where the maximum inward amplitude
occurred during step depolarizations. Fig. 5 B shows the
average peak Ca2þ current density plotted against voltage
(I-V) from control (black circles), Mut-DP4 (blue circles),
and DP4-treated fibers (red circles). Addition of 100 mM
DP4 induced ~47% enhancement of the peak inward Ca2þ
current density as illustrated in Fig. 5 B. The solid lines
through the I-V curves in Fig. 5 B are least-squares fits of
the data to a modified Boltzmann-Ohmic equation (8,33),
I ¼ GmaxðV  VrevÞ=

1þ exp V  Vhalf

k

; (7)where Gmax is the maximum conductance, V is the
membrane potential, Vrev is the reversal potential, Vhalf is
the half-activation potential, and k is a measure of the steep-
ness. Average parameter values from Gmax, Vh, k, and Vrev
for control fibers were: 157.0 5 0.2 pA/mV, 11.1 5
0.7 mV, 3.45 0.5 mV, and 425 4 mV. The corresponding
sets of values for the Mut- DP4 were: 139.35 0.2 pA/mV,
11.45 0.8 mV, 3.75 0.5 mV, and 485 6 mV, whereas
values corresponding to DP4 were 195.3 5 0.3 pA/mV,
10.4 5 0.6 mV, 2.8 5 0.8 mV, and 49 5 7 mV. These
parameters were used to obtain voltage dependence of
Ca2þ conductance for the control, Mut-DP4, and DP4 fibers
(Fig. 5 C).
DP4 induced a significant 24% enhancement on Gmax
(P < 0.05, N ¼ 8) whereas Mut-DP4 did not cause any
significant change in the properties of whole-cell Ca2þ
current. We concluded that the enhancement of the Ca2þ
current caused by addition of DP4 is voltage-independent,
judging by the negligible effects on both Vhalf and k Boltz-
mann’s parameters of the Ca2þ channel conductance.DP4 potentiates action-potential induced Ca2D
transients in skeletal muscle FDB fibers
One additional and interesting finding of an earlier report
was that DP4 did not significantly alter the size of the twitch
response elicited by action potential (AP) stimulation in me-
chanically peeled fibers (31). To address whether DP4FIGURE 5 Intracellular dialysis of DP4
enhances macroscopic Ca2þ current in FDB fibers.
(A) Representative macroscopic Ca2þ current
traces from 100 mM Mut-DP4-dialyzed (blue
trace), control (black trace), and 100 mMDP4-dia-
lyzed fibers (red trace) elicited by a test depolar-
ization to 0 mV. Macroscopic currents were
elicited by 80-ms depolarizing pulses using
2 mM Ca2þ as the charge carrier. (Vertical dashed
lines) Time used to measure average current
density values to create I-V plots. (B) I-V relation-
ships of average data from Mut-DP4-dialyzed
(blue symbols), control (black symbols), and
DP4-dialyzed fibers (red symbols). The solid lines
through the I-V profiles in panel B are least-squares
fits of the data to a modified Boltzmann-Ohmic
equation, Eq. 7 (see Results). (C) Ca2þ conduc-
tance versus voltage (GCa-V) relationship of
Mut-DP4, control, and DP4-dilayzed fibers derived
from Eq. 7. These results indicate that DP4
induced a significant 24% enhancement on Gmax
(N ¼ 8; P < 0.05).
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2374 Olojo et al.enhances AP-evoked Ca2þ release in fibers with intact
sarcolemma and open transverse tubules, we voltage-
clamped fibers using the AP waveform (Fig. 6 A), inter-
spersed with depolarizing pulses to 20 mV (see Fig. S5).
The averaged AP evoked Ca2þ transients measured in
control (black trace; n ¼ 5) and DP4-dialyzed fibers (red
trace, n ¼ 5) in Fig. 6 B show that DP4 (100 mM) enhanced
the AP evoked Ca2þ transients as measured by F/F0 values.
Fig. 6 C shows time course of calculated free [Ca2þ]
obtained from Eq. 3, demonstrating a 57% enhancement
of peak free [Ca2þ] during an AP voltage-clamp when fibers
were dialyzed with 100 mMDP4. Similarly, the Ca2þ release
flux calculated from Eq. 5 shows 68% potentiation of the
AP-evoked Ca2þ release upon addition of DP4 as illustrated
in Fig. 6 D (control peak Ca2þ release flux (mM ms1) ¼
48 vs. 81 for DP4 dialyzed fibers; N ¼ 5, P < 0.05). For
comparison, Ca2þ transients and the corresponding time
course of free [Ca2þ] and Ca2þ release elicited by a 80-msBiophysical Journal 100(10) 2367–2377depolarizing pulse to 20 mV in the same fibers is illus-
trated in Fig. 6, E–H. The above results indicate that DP4
enhances Ca2þ release, both for voltage-clamp pulses and
for the voltage-clamp-imposed AP command.DISCUSSION
This report describes the effects of the DP4 peptide on depo-
larization-induced global SR Ca2þ release detected by ultra
high-speed laser confocal microscopy in whole-cell voltage-
clamped adult FDB skeletal muscle fibers. DP4 is a domain
peptide corresponding to the Leu2442-Pro2477 region of the
RyR1 central domain (21). Interaction of DP4 with its com-
plimentary domain within the RyR1 interferes with normal
intrachannel domain-domain interaction that is hypothe-
sized to play a key role in stabilizing one of the closed states
of the channel (24). Thus the peptide is believed to unzip the
interacting N-terminal and central domains (18,21,22,25), toFIGURE 6 DP4 enhances AP-evoked Ca2þ tran-
sients and Ca2þ release. AP waveform (A) or
80-ms step depolarization (E) used to evaluate
the effect of DP4. Time course of F/F0 obtained
from control fibers (black trace) and from
100 mM DP4-dialyzed fibers (red traces) using
AP waveform (B) or step depolarization (F).
(C and G) Free [Ca2þ] waveforms derived from
panels B and F calculated using Eq. 3 (see Mate-
rials and Methods). (D and H) Ca2þ release flux,
calculated from Eq. 5. (Insets) Zoom-in versions
of the rising phase of Ca2þ release from control
and DP4-dialyzed fibers.
DP4 Regulates E-C Coupling 2375activate the RyR1 Ca2þ release channel by itself (23–25,31),
and to hypersensitize the channel for its activation by phar-
macological agonists such as caffeine (26). Here we show
that DP4 also increases the effectiveness of the DHPR
transverse tubule voltage sensor to activate the RyR during
depolarization of whole-cell, voltage-clamped adult skeletal
muscle fibers.
The central domain of RyR1 contains mutations for both
malignant hyperthermia (MH) and central core disease
(26,45–49). Malignant hyperthermia is a dangerous hyper-
metabolic state after anesthesia with suxamethonium and/
or volatile halogenated anesthetic agents (28). Studies on
the Ca2þ release properties of RyR1 channels containing
MH mutations expressed in nonmuscle cells (50), myotubes
(27,51–53), and muscle fibers (54,55) as well as animal
models of MH (27,30) and humans (28,29), demonstrated
that these MH mutations cause channel hyperactivation
and hypersensitization effects.
DP4 produced MH-like hyperactivation of the wild-type
RyR channel as described above, whereas it produced virtu-
ally no additional effect on the MH mutant RyR1 channels
(22). Furthermore, as was shown previously, and in this study
as well, Mut-DP4 that has the R2458C MH mutation in it
produces no hyperactivation or hypersensitization effects.
Previous work in mechanically peeled skeletal muscle has
shown that DP4 enhanced the force response to caffeine
and to submaximal depolarization by change in ionic com-
position of the bathing solution, but that DP4 had no effect
on the force response elicited by single AP (31). In particular,
the influence of DP4 on depolarization-evoked Ca2þ release
has not been evaluated in adult whole-cell, voltage-clamped
skeletal fibers. Here we first demonstrate that in murine
voltage-clamped fibers, DP4 increases the amplitude of depo-
larization-induced Ca2þ release without appreciably altering
either its voltage-dependence or the kinetic properties of
initial phase of the Ca2þ release flux. DP4 induced an en-
hancement of ~64% on depolarization-evoked Ca2þ release,
thus confirming previous findings (23–25,31) regarding the
potentiating effects of DP4 on Ca2þ release, but here using
voltage-clamp depolarization-evoked Ca2þ release.
We also used the AP voltage-clamp technique simulta-
neously with high-speed confocal measurement of fluo-
rescent Ca2þ transients to establish that DP4 enhances
AP-evoked Ca2þ release. The difference between our results
and a previous study (31) may reflect differences in method-
ology (skinned versus whole-cell voltage-clamped) and/or
species differences (mouse versus rat). One disadvantage
common to both the skinned fiber preparation and the
whole-cell patch-clamp techniques is the potential loss of
important intracellular constituents (34,56,57)—a process
that could be faster in the skinned fiber preparation, and one
which might explain the difference between these studies.
We also searched for potential effects of DP4 on the
voltage-sensing machinery of the E-C coupling by mea-
suring nonlinear capacitive currents to evaluate the proper-ties of intramembrane charge movement. Interestingly,
DP4 did not modify either the amplitude or the voltage
dependence of the intramembrane charge movement, indi-
cating that the voltage sensor machinery required for the
activation of both RyR Ca2þ release and DHPR Ca2þ
current (2–4,6) was not modified by this treatment. One
striking observation was that DP4 also increased (24%)
the maximum Ca2þ conductance (Gmax) without affecting
either the voltage-dependence or the steepness of the Ca2þ
conductance versus voltage relationship. In contrast, appli-
cation of 100 mM of Mut-DP4, a peptide identical to DP4
except for an R-2458-C mutation, had no appreciable effect
on either depolarization-evoked Ca2þ release or L-type
Ca2þ currents.
Our results demonstrate that in voltage-clamped fibers,
DP4 induces two main effects on E-C coupling. The first
effect is to sensitize final steps of orthograde E-C coupling.
In this case, the effect of DP4 is to enhance depolarization-
evoked Ca2þ release via a direct regulation of RyR1 Ca2þ
release channel without affecting the voltage-sensing
machinery of the DHPR. This effect is believed to be medi-
ated by DP4 competing with its corresponding endogenous
domain within RyR1 for binding to its complimentary
N-terminal domain binding site within RyR1 (18,24,25),
thereby destabilizing intramolecular signal-conduction
pathway of the RyR1 and sensitizing activation of ortho-
grade E-C coupling. Our results are consistent with the
hypothesis that conformational changes in the DHPR
T-tubule voltage sensor (5–7) and those in the RyR1 domain
switch, which has been suggested to represent a putative
channel regulatory domain (18,21,22,24,25), are tightly
coupled. Thus, any mechanisms that reduce the energy
barrier to destabilize tight interaction between the
N-terminal domain and central domain, such as the presence
of DP4, would facilitate turning the domain switch from off-
position to on-position.
The second effect of DP4 on E-C coupling is possibly
mediated by retrograde signaling between the RyR1 and
L-type Ca2þ channels. This form of signaling may induce
an L-type channel state(s) with a higher open probability,
perhaps the result of longer openings or shorter closed times
(58), which in turn translates into enhanced Ca2þ entry.
Because of the lack of effect of DP4 on the voltage depen-
dence of the charge movement or the Ca2þ conductance, the
augmentation on Gmax may arise from transitions that do not
involve or require small charge movement (59). Whether
this effect is a consequence of direct retrograde signaling
or the result of a Ca2þ-dependent process (i.e., calmod-
ulin-mediated Ca2þ-dependent facilitation) remains to be
determined.CONCLUSIONS
Our results provide what we believe to be new information
about the effects of DP4, a peptide derived from the centralBiophysical Journal 100(10) 2367–2377
2376 Olojo et al.domain of the RyR1, on orthograde and retrograde E-C
coupling. Our results also suggest the hypothesis that DP4
can alter the intramolecular transduction of the activation
signal within the RyR1, as well as the molecular communi-
cation from RyR1 to the skeletal muscle L-type Ca2þ
channel. It is clear that future studies are needed and that
they will require detailed structural and molecular studies
to identify the exact location(s) and interactions between
critical regulatory domains in both DHPR and RyR1 as
well as the exact functional consequences of such interac-
tions. Overall, this domain peptide approach can be used
as a tool to modulate and further study bidirectional
signaling between DHPR-RyRs in skeletal muscle.SUPPORTING MATERIAL
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